Emerging diseases in tropical dermatology (Q37045251)

17 August 2017

1 reference

title

Emerging diseases in tropical dermatology (English)

1 reference

17 August 2017

Whitney A High

1

1 reference

PubMed ID

18159908

17 August 2017

Francisco G Bravo

series ordinal

2

1 reference

17 August 2017

1 January 2007

1 reference

17 August 2017

Advances in dermatology

1 reference

17 August 2017

23

1 reference

17 August 2017

335-350

1 reference

Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR.

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Balamuthia mandrillaris from soil samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Balamuthia amebic encephalitis risk, Hispanic Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Standardized method of measuring acanthamoeba antibodies in sera from healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Amoeba angeitic lesions of the central nervous system in Balamuthia mandrilaris amoebiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

New and re-emerging cutaneous infectious diseases in Latin America and other geographic areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Granulomatous cutaneous centrofacial and meningocerebral amebiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Successful Treatment of Balamuthia Amoebic Encephalitis: Presentation of 2 Cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Human gnathostomiasis in Ecuador (nodular migratory eosinophilic panniculitis). First finding of the parasite in South America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Gnathostomiasis: an emerging imported disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Clinical gnathostomiasis: case report and review of the English-language literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Eosinophilic meningitis and radiculomyelitis in Thailand, caused by CNS invasion of Gnathostoma spinigerum and Angiostrongylus cantonensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Clinical manifestations and immunodiagnosis of gnathostomiasis in Culiacan, Mexico.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Gnathostomiasis without eosinophilia led to a 5-year delay in diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Diagnostic values of IgG4 in human gnathostomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

A review of human sparganosis in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Disseminated Penicillium marneffei infection in southeast Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Systemic Penicillium marneffei infection in a German AIDS patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Pulmonary penicillosis marneffei: report of the first imported case in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Cutaneous manifestations of Penicillium marneffei infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Penicillium marneffei infection diagnosed by polymerase chain reaction from the skin specimen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Development and evaluation of a one-tube seminested PCR assay for the detection and identification of Penicillium marneffei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Human pythiosis, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Mechanics of solid tissue invasion by the mammalian pathogen Pythium insidiosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Clinical and Epidemiological Analyses of Human Pythiosis in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

A method to obtain rapid zoosporogenesis of Pythium insidiosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Induction of zoospore formation in Thai isolates of Pythium insidiosum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Immunodiffusion test for diagnosing human pythiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Identification of emerging human-pathogenic Pythium insidiosum by serological and molecular assay-based methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Human subcutaneous pythiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Phylogenetic spectrum of fungi that are pathogenic to humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Newer antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Penicilliosis marneffei and pythiosis: emerging tropical diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Hydroa vacciniforme: A clinical and follow-up study of 17 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

WHO-EORTC classification for cutaneous lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Short report: gnathostomiasis in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Life cycle of the human and animal oomycete pathogen Pythium insidiosum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Immunodiffusion test for diagnosis and monitoring of human pythiosis insidiosi

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.008

7 January 2021

10.1016/J.YADR.2007.07.008

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18159908